4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000035
Chief Financial Officer sold 7,989 shares at an average $16.78 ($134,036)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Davis Blaine Chief Financial Officer | 2025-01-03 | Sale | −3,961 | $16.72 | $66,235 | 98,839 | D: show line 1 in the form |
| Davis Blaine Chief Financial Officer | 2025-01-06 | Sale | −4,028 | $16.83 | $67,800 | 94,811 | D: show line 2 in the form |
| Open-market sales · 7,989 sh · avg $16.78 · $134,036 | |||||||
Loading xslF345X05/wk-form4_1736298282.xml…